X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES PLETHICO PHARMA JUBILANT LIFE SCIENCES/
PLETHICO PHARMA
 
P/E (TTM) x 20.5 -1.1 - View Chart
P/BV x 4.4 0.0 26,019.9% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   PLETHICO PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
PLETHICO PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs187395 47.3%   
Low Rs6531 208.0%   
Sales per share (Unadj.) Rs364.3604.4 60.3%  
Earnings per share (Unadj.) Rs6.832.5 21.1%  
Cash flow per share (Unadj.) Rs24.551.3 47.7%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9473.6 34.8%  
Shares outstanding (eoy) m159.2834.08 467.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 98.0%   
Avg P/E ratio x18.46.6 280.4%  
P/CF ratio (eoy) x5.14.2 123.8%  
Price / Book Value ratio x0.80.5 169.7%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0617,262 276.2%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,596 692.5%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03420,598 281.7%  
Other income Rs m191386 49.3%   
Total revenues Rs m58,22420,984 277.5%   
Gross profit Rs m5,7862,818 205.4%  
Depreciation Rs m2,812642 437.8%   
Interest Rs m3,2371,593 203.2%   
Profit before tax Rs m-72969 -7.4%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696-138 -503.3%   
Profit after tax Rs m1,0901,107 98.5%  
Gross profit margin %10.013.7 72.9%  
Effective tax rate %-965.9-14.3 6,760.0%   
Net profit margin %1.95.4 35.0%  
BALANCE SHEET DATA
Current assets Rs m29,28018,877 155.1%   
Current liabilities Rs m38,91211,896 327.1%   
Net working cap to sales %-16.633.9 -49.0%  
Current ratio x0.81.6 47.4%  
Inventory Days Days8436 234.8%  
Debtors Days Days51198 25.6%  
Net fixed assets Rs m55,7129,861 565.0%   
Share capital Rs m155341 45.3%   
"Free" reserves Rs m20,96812,331 170.0%   
Net worth Rs m26,26516,139 162.7%   
Long term debt Rs m17,1694,706 364.8%   
Total assets Rs m88,60633,146 267.3%  
Interest coverage x1.01.6 60.8%   
Debt to equity ratio x0.70.3 224.2%  
Sales to assets ratio x0.70.6 105.4%   
Return on assets %4.98.1 60.0%  
Return on equity %4.26.9 60.5%  
Return on capital %11.612.3 94.1%  
Exports to sales %37.821.4 176.8%   
Imports to sales %16.515.2 108.3%   
Exports (fob) Rs m21,9334,402 498.2%   
Imports (cif) Rs m9,5673,136 305.1%   
Fx inflow Rs m22,0044,402 499.8%   
Fx outflow Rs m11,7493,184 369.0%   
Net fx Rs m10,2551,219 841.6%   
CASH FLOW
From Operations Rs m8,0262,437 329.3%  
From Investments Rs m-1,744-6,265 27.8%  
From Financial Activity Rs m-4,4472,490 -178.6%  
Net Cashflow Rs m1,834-1,337 -137.2%  

Share Holding

Indian Promoters % 45.6 82.7 55.1%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.3 202.3%  
FIIs % 21.2 5.5 385.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 7.5 281.3%  
Shareholders   23,815 10,665 223.3%  
Pledged promoter(s) holding % 15.9 85.7 18.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   DIVIS LABORATORIES  WOCKHARDT LTD.  ASTRAZENECA PHARMA  SHASUN PHARMA  IPCA LABS  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 23, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS